On the 15th of August, drug Kadycla (trastuzumab emtansin) is finally approved by the Beslutningsforum and ready to help hundreds with breast cancer in Norway. The drug, developed by company Roche, specifically targets patients with the variant HER2 positive breast cancer – a breast cancer that tests positive for human epidermal growth factor receptor 2, […]
Author Archive for: oslocancer
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 309 entries.
Entries by oslocancer
We are proud to introduce Oslo Cancer Cluster’s new members. This is the second part of two stories about our new members. You can find the first part HERE. On the 24th of August, Oslo Cancer Cluster hosted a bustling summer party in the Oslo Cancer Cluster Incubator, where the new members had the chance to introduce […]
We are proud to introduce Oslo Cancer Cluster’s new members. This is the first part of two stories about our new members. You can find the second part HERE. On the 24th of August, Oslo Cancer Cluster hosted a summer party with the intention of getting to know their newest members in an informative and fun […]
The Research Council of Norway has given Thermo Fisher Scientific the prestigious Innovation Award for their Dynabeads. The Oslo Cancer Cluster member Thermo Fischer Scientific was awarded the prize for developing an entirely new variant of an existing product, making it possible to analyse human genes quickly and effectively and improve diagnostic testing and patient […]
Sentrale fagmiljøer og helsepolitikere møttes på Oslo Cancer Clusters første åpne møte under Arendalsuka. De diskuterte hva persontilpasset medisin har potensial til å være – og hva som skal til for å oppnå resultater av forskning og klinisk bruk. Hva er egentlig persontilpasset medisin? Det handler enkelt forklart om at forebygging og behandling av sykdom […]
Interested pupils at Ullern Upper Secondary School arrive at laboratory 117 to learn alongside Dr. Bora Sieng, a chemist in Arctic Pharma. Dr. Sieng advocates for the importance of chemistry and encourages pupils to pursue a career in the exciting field of chemistry. At nine o’clock in the morning, three boys eagerly gather outside laboratory room 117. They’re […]
What kind of work does it take to receive PERMIDES funding for innovative concepts and projects? Meet one of the companies that just received funding. 22 collaboration projects will receive a total of 1,25 Million Euros from PERMIDES for innovation projects between small and medium sized enterprises (SMEs) from biopharma, bioinformatics and the IT […]
The project DoMore! aims to achieve better and faster diagnosis and prognosis with information and communication technology solutions. Technological innovation brightens the future ahead. With an increase in investment towards these areas, we create not only further potential in the technological field, but see betterment in the area it was produced for – such […]
The Department of Cellular Therapy is great at transforming cancer research into new companies. The latest spin-out is Zelluna. The Department of Cellular Therapy at the Radium Hospital, Oslo University Hospital, features one of Europe’s largest and most modern good manufacturing practice (GMP) facilities for cellular products. Head of the department is Prof. Gunnar Kvalheim. They […]
24 oncology innovators from 9 international hubs attended the 6th International Cancer Cluster Showcase in San Diego. The International Cancer Cluster Showcase (ICCS) was born back in 2011 in Washington DC, during the world’s largest biotech conference, BIO International Convention. International cluster managers and representatives from the oncology field in Boston, Toulouse and Oslo […]
Contact Team >
Oslo Cancer Cluster Incubator will support promising oncology biotechs to commercialize successfully.
The Incubator provides a dynamic, creative, and professional growth environment for scientists and start-ups.